HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants
Fig 1
Quorum flow chart of study inclusion.
Illustration of the number of articles identified in the literature search and reasons for exclusion.